Company intelligence / Profile preview
BioVinc
- Ownership
- Private
- Employees
- ~7
- Development stage
- Other
Overview
BioVinc is a pre-clinical biotechnology company specializing in the development of bone-targeted therapeutics and diagnostic molecular probes for skeletal diseases and infections. Utilizing its proprietary 'Smart Targeting' platform technology, the company designs skeletal-selective drug conjugates by linking therapeutic agents to bisphosphonates, which have a high affinity for bone minerals. BioVinc's lead pipeline candidate, OsteoFloxacin™ (BV63072), is a bone-targeted sitafloxacin conjugate designed to eradicate biofilms and treat prosthetic joint infections (PJI) and osteomyelitis. Additionally, the company is developing bone-targeted therapies for multiple myeloma and osteonecrosis of the jaw, alongside a commercialized portfolio of fluorescent imaging probes for bone research.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- Small moleculeDevice
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on BioVinc.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioVinc.